Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |